Category: Medications - Page 2

Partial AUC is an advanced bioequivalence tool that measures drug exposure during key time windows, ensuring complex generics like extended-release painkillers match brand-name performance. It catches differences traditional metrics miss.

Health systems are using stockpiling, AI predictions, supplier diversification, and pharmacist-led substitutions to fight drug shortages. Learn how hospitals are preventing crises before they happen.

Learn how generic drugs are classified by therapeutic use, mechanism of action, legal status, insurance tiers, and global standards. Understand why your prescription works the way it does.

Taking vitamin E with warfarin can increase bleeding risk-even if your INR looks normal. Learn the real danger, what doses are risky, and what clinics are telling patients right now.

The FDA Orange Book lists all approved generic drugs and their therapeutic equivalence to brand-name versions. It's the key resource for pharmacists, doctors, and insurers to determine which generics can be safely substituted.

Keep prescription labels and leaflets organized to prevent dangerous medication errors. Learn how to store them physically and digitally for long-term safety and peace of mind.

Generic drug markets are set to grow to over $700 billion by 2030, driven by patent expirations, aging populations, and cost pressures. Biosimilars, India and China's manufacturing power, and tech-driven efficiency are reshaping global healthcare affordability.

Learn how to take levothyroxine correctly to avoid absorption issues caused by food, coffee, calcium, and other common substances. Timing matters more than most people think.

FDA generic drug approvals save billions each year, with total savings reaching $445 billion in 2023. Year-by-year breakdowns show spikes when big drugs lose patents, and patients pay up to 90% less with generics.

Governments don't set prices for generic drugs - they let competition do the work. Learn how policies like Hatch-Waxman, FDA approvals, and FTC enforcement keep generics affordable without price controls.